Please login to the form below

Not currently logged in
Email:
Password:

Andreas Busch

This page shows the latest Andreas Busch news and features for those working in and with pharma, biotech and healthcare.

Shire’s angioedema drug Takhzyro recommended in Europe

Shire’s angioedema drug Takhzyro recommended in Europe

Andreas Busch, executive vice president, head of research and development at Shire.

Latest news

  • Shire’s bleeding disorder drug approved in Europe Shire’s bleeding disorder drug approved in Europe

    Andreas Busch, head of research and development and chief scientific officer, Shire, said: “The approval in Europe for VEYVONDI marks a key milestone in our efforts to tackle unmet medical needs ... Busch added: “We are excited to take the next steps

  • Shire’s Maribavir wins US breakthrough therapy designation Shire’s Maribavir wins US breakthrough therapy designation

    Andreas Busch, global head of R&D at Shire, said: “Maribavir has the potential to address critical medical needs for transplant patients who are refractory or resistant to currently available antiviral ... Busch added: “We are delighted that the FDA

  • Joerg Moeller to head Bayer R&D after operational shake-up Joerg Moeller to head Bayer R&D after operational shake-up

    Andreas Busch to move to Shire as head of R&D and CSO. ... The restructuring means Andreas Busch - current head of drug discovery at the German company - is heading for the exit, but has already lined up another senior position at Shire, where he

  • J&J and Bayer unveil new bioincubators J&J and Bayer unveil new bioincubators

    The CoLaborator is a "logical step in enhancing our partnership models in research", commented Bayer's head of global drug discovery Andreas Busch, adding that it is "an important element of

  • Bayer establishes research centre in Beijing Bayer establishes research centre in Beijing

    Prof Dr Andreas Busch, Bayer's head of global drug discovery, explained that the partnership was part of collaborative approach to research that many pharma companies now have as part of

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics